candesartan has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, K | 1 |
| Mashima, Y | 1 |
| Fumayama, T | 1 |
| Ohtake, Y | 1 |
| Kimura, I | 1 |
| Yoshida, K | 1 |
| Ishikawa, K | 1 |
| Yasuda, N | 1 |
| Fujimaki, T | 1 |
| Asaoka, R | 1 |
| Koga, T | 1 |
| Kanamoto, T | 1 |
| Fukuchi, T | 1 |
| Miyaki, K | 1 |
1 trial available for candesartan and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Genetic polymorphisms in the angiotensin II receptor gene and their association with open-angle glaucoma in a Japanese population.
Topics: Administration, Oral; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Ant | 2005 |